Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

The Microbiome

Jose U. Scher, MD, Steven B. Abramson, MD  |  

A voyage to (our inner) Lilliput

Dispelling the Mystery, Ensuring the Future

  |  

Bringing calm and organization to chaos: This is what led Greg Dennis, MD, to pursue a career in rheumatology. Dr. Dennis who, at the time, was an internal medicine resident at Fitzsimons Army Medical Center in Aurora, Colo., was seeking a subspecialty that would allow him to pursue immunology in a clinical or laboratory setting. What he realized during his residency was that rheumatology was a mystery to many physicians.

Rheumatology Professionals and Patient Advocates Take Their Stories to Capitol Hill

  |  

The ACR’s annual Advocates for Arthritis conference, September 19–20, brought more than 120 rheumatologists, rheumatology health professionals, and patient advocates to our nation’s capital. Attendees, representing 37 states, met with more than 175 congressional offices, sharing their stories of access to care, treatment, and the importance of research.